Hibergene
Rapid molecular tests for infectious disease
Hibergene has raised €6.1M across 1 funding round, most recently a Series B round in Mar 2017. Based in Dublin, Ireland; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.1M
€6,095,774
Funding rounds
1
Investors
0
distinct backers
Active since
2017-03
latest 2017-03
Funding by year
EUR raised per yearHibergene — funding by year — interactive chart.
Data table
| Hibergene — funding by year | |
|---|---|
| 2017 | €6.1M |
Signals
Medium confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Series B | €6.1M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData